PM
Philip Morris International Inc.
NYSE · Consumer Defensive · Tobacco · US
$183.88
−1.23%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 42.5B | 40.6B | 37.9B | 35.2B | 31.8B |
| Cost of Revenue | 13.8B | 13.4B | 13.3B | 12.9B | 11.4B |
| Gross Profit | 28.7B | 27.3B | 24.5B | 22.3B | 20.4B |
| Operating Expenses | |||||
| R&D Expense | — | — | 759.0M | — | — |
| SG&A Expense | 12.4B | 12.3B | 11.1B | 10.1B | 8.1B |
| General & Admin Expense | 2.9B | — | 11.1B | 10.1B | 8.1B |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 303.0M | — | (759.0M) | 665.0M | — |
| Total Operating Expenses | 12.7B | 12.3B | 11.1B | 10.7B | 8.1B |
| Cost and Expenses | 26.5B | 25.7B | 24.5B | 23.6B | 19.5B |
| Operating Income (EBIT) | 16.1B | 14.9B | 13.4B | 11.6B | 12.2B |
| Non-Operating | |||||
| Interest Income | — | 621.0M | 620.0M | 465.0M | 180.0M |
| Interest Expense | 1.5B | 1.6B | 1.8B | 1.5B | 768.0M |
| Net Interest Income | (1.5B) | (966.0M) | (1.1B) | (1.1B) | (588.0M) |
| Other Non-Op Income/Expense | (1.2B) | (348.0M) | (1.2B) | (949.0M) | (475.0M) |
| Non-Operating Income (excl Interest) | (608.0M) | (534.0M) | (560.0M) | (420.0M) | (156.0M) |
| EBT (Pre-Tax Income) | 14.8B | 14.6B | 12.2B | 10.6B | 11.8B |
| Income Tax Expense | 3.1B | 2.7B | 2.4B | 2.3B | 2.2B |
| Bottom Line | |||||
| Net Income | 10.9B | 11.3B | 7.0B | 7.8B | 9.0B |
| Earnings from Cont. Ops | 11.8B | 11.8B | 9.8B | 8.3B | 9.5B |
| Earnings from Discont. Ops | 18.0M | — | (23.0M) | (157.0M) | — |
| Bottom Line Net Income | 10.9B | 11.3B | 7.0B | 7.8B | 9.0B |
| Per Share | |||||
| Basic EPS | $6.96 | $7.27 | $4.53 | $5.02 | $5.82 |
| Diluted EPS | $6.96 | $7.26 | $4.52 | $5.02 | $5.81 |
| Revenue Per Share | $27.22 | $26.12 | $24.37 | $22.66 | $20.49 |
| Shares | |||||
| Basic Shares Outstanding | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B |
| Diluted Shares Outstanding | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B |
| Profitability Metrics | |||||
| EBITDA | 18.2B | 17.5B | 15.7B | 13.4B | 13.5B |
| D&A | 1.5B | 2.0B | 1.8B | 1.4B | 1.1B |
| EBIT | 16.7B | 15.5B | 14.0B | 12.0B | 12.4B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026